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ABSTRACT Local cerebral serotonin synthesis capacity was measured with a-[C-
11]methyl-L-tryptophan ([C-11]AMT) in normal adult human brain (n 5 10; five males,
five females; age range, 18–38 years, mean 28.3 years) by using positron emission
tomography (PET). [C-11]AMT is an analog of tryptophan, the precursor for serotonin
synthesis, and is converted to a-[C-11]methyl-serotonin ([C-11]AM-5HT), which is
trapped in serotonergic neurons because [C-11]AM-5HT is not degraded by monoamine
oxidase. Kinetic analysis of [C-11] activity in brain after injection of [C-11]AMT
confirmed the presence of a compartment with unidirectional uptake that represented
approximately 40% of the activity in the brain at 50 min after tracer administration. The
undirectional rate constant K, which represents the uptake of [C-11]AMT from the
plasma to brain tissue followed by the synthesis and physiologic trapping of [C-11]AM-
5HT, was calculated using the Patlak graphic approach on a pixel-by-pixel basis, thus
creating parametric images. The rank order of K values for different brain regions
corresponded well to the regional concentrations of serotonin in human brain (P , .0001).
High serotonin synthesis capacity values were measured in putamen, caudate, thala-
mus, and hippocampus. Among cortical regions, the highest values were measured in the
rectal gyrus of the inferior frontal lobe, followed by transverse temporal gyrus; anterior
and posterior cingulate gyrus; middle, superior, and inferior temporal gyri; parietal
cortex; occipital cortex, in descending order. Values in women were 10–20% higher
(P , .05, MANOVA) throughout the brain than those measured in men. Differences in
the serotonin synthesis capacity between men and women measured in this study may
reflect gender differences of importance to both normal and pathologic behavior. This
study demonstrates the suitability of [C-11]AMT as a tracer for PET scanning of
serotonin synthesis capacity in human brain and provides normal adult values for future
comparison with patient groups. Synapse 28:33–43, 1998. r 1998 Wiley-Liss, Inc.
INTRODUCTION
Serotonin (5-hydroxytryptamine, 5HT) is phylogeneti-
cally the oldest of the biogenic amine neurotransmit-
ters. This may account for the finding that more
receptors have evolved for this amine than for any other
known neurotransmitter (Peroutka, 1994). Pharmaco-
logic and molecular genetic evidence have demon-
strated evolution of at least three classes of 5HT
receptors (5HT1, 5HT2, 5HT3) and possibly up to seven
classes based on structural and functional characteris-
tics (for classification, see Hoyer et al., 1994), with the
members of these families totaling at least 14 distinct
molecular entities. The study of these receptors both in
vitro and in vivo has been hindered by the lack of
specific pharmacologic agents. Indeed, much of the
pharmacologic classification of these receptors has re-
lied on ligand and multiple displacing agents to define
the location and function of specific 5HT receptors.
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In vivo imaging using probes aimed at investigating
serotonergic function has been an area of great interest
because serotonergic neurotransmission is postulated
to provide a tonic modulatory role in brain development
and is important in such diverse functions as feeding,
sleep, sexual behavior, and mood (for review, see Jacobs
and Azmitia, 1992). In addition, there is evidence that
abnormalities of serotonergic neurotransmission are
associated with several neurologic and psychiatric dis-
orders, including autism, migraine, sleep disorders,
depression, movement disorders, and epilepsy (for re-
views, see Murphy, 1990; Roth, 1994).
a-[C-11]Methyl-L-tryptophan ([C-11]AMT), which has
been developed as a tracer for serotonin synthesis with
positron emission tomography (PET) (Diksic et al.,
1991), is an analog of tryptophan, the precursor for
serotonin synthesis. After the administration of labeled
or unlabeled a-methyl-L-tryptophan (AMT) in rats,
conversion to a-methyl-serotonin (AM-5HT) in brain
has been demonstrated by high-pressure liquid chroma-
tography (HPLC) (Diksic et al., 1990; Missala and
Sourkes, 1988). [H-3]a-methyl-serotonin ([H-3]AM-
5HT) synthesized in brain was localized to serotonergic
neurons and nerve terminals by combined autoradiogra-
phy and tryptophan hydroxylase immunocytochemis-
try at the electron microscopic level (Cohen et al., 1995).
Furthermore, [H-3]AM-5HT present in nerve terminals
could be released by potassium-induced depolarization,
suggesting that this tracer is stored with the releasable
pool of serotonin (Cohen et al., 1995). Because AM-5HT,
unlike serotonin, is not a substrate for the degradative
enzyme monoamine oxidase (Missala and Sourkes,
1988), accumulation of AM-5HT occurs in serotonergic
terminals. In addition, AMT, unlike tryptophan, is not
incorporated into protein in significant amounts (Diksic
et al., 1990; Madras and Sourkes, 1965). These proper-
ties simplify the kinetic modeling of AMT, making it a
suitable tracer substance for the study of serotonin
synthesis in vivo. We now report the measurement of
local cerebral serotonin synthesis capacity with [C-
11]AMT in normal adult human brain by using PET.
METHODS
Theory
Studies of [C-14]AMT in rat (Diksic et al., 1990) and
[C-11]AMT in dog (Diksic et al., 1991) have demon-
strated that the kinetic behavior of the tracer AMT can
be described by a three-compartment model using
first-order rate constants (schematically represented in
Fig. 1). The inflow rate constant K1 (ml/g/min) and the
outflow rate constant k2 (1/min) both describe the
exchange of [C-11]AMT between vascular space and the
cell cytoplasm (transport across the blood-brain barrier,
the interstitial space, and the cell membrane). Approxi-
mately 20% of AMT in plasma is bound to albumin,
whereas 90% of plasma tryptophan is bound (Shoaf and
Schmall, 1996). AMT competes with tryptophan and
other large neutral amino acids for transport across the
blood-brain barrier (Diksic et al., 1990). Once present in
the cytoplasm of serotonergic neurons (Cf), [C-11]AMT
is converted to [C-11]AM-5HT (Cm) by means of an
irreversible, two-step enzymatic process, which is char-
acterized by the rate constant k3 (1/min). The rate-
limiting step of this process is the irreversible hydrox-
ylation of [C-11]AMT to [C-11]AM-5-hydroxy-tryptophan
mediated by tryptophan hydroxylase. The solution for
the set of differential equations describing the three-
compartment model shown in Figure 1 has been previ-
ously reported (Sokoloff et al., 1977). Reliable estimates
of the individual rate constants K1, k2, and k3 for
[C-11]AMT by using this method, however, could only
be obtained for large regions of the brain due to the low
identifiability of the model, which is caused by the low
count statistics originating from the low single-pass
extraction fraction of the tracer (approximately 2%) and
the short physical half-life of [C-11] (Muzik et al., 1997).
The graphic approach described by Patlak et al.
(1983) is an alternative method of analysis that allows
the determination of the undirectional uptake rate
constant K, which represents the uptake of [C-11]AMT
from the plasma to brain tissue followed by the synthe-
sis and physiologic trapping of [C-11]AM-5HT. This
approach assumes that the system to be analyzed
consists of a homogenous tissue region with any num-
ber of compartments that communicate reversibly with
the blood. In addition, there must be at least one
compartment that the tracer enters in an irreversible
manner. As discussed by Patlak et al. (1983), at long
enough times after administration of tracer (t . t*), the
amount of tracer in the reversible compartments will be
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Fig. 1. Three compartment model for [C-11]AMT kinetics in brain.
The inflow rate constant K1 and the outflow rate constant k2 both
describe the exchange of [C-11]AMT between vascular space (Cp) and
the cell cytoplasm (Cf ). Once present in Cf, [C-11]AMT is converted to
[C-11]AM-5HT (Cm) by means of an irreversible, two-step enzymatic
process, which is characterized by the rate constant k3. The PET tissue
signal is denoted as CPET and represents a combination of both the Cf
and Cm signals.
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where CPET(t) is the measured [C-11] tissue concentra-
tion at midscan time ti, Cp(t) is the concentration of
[C-11]AMT in plasma at time t, K is the rate constant
for unidirectional uptake of [C-11]AMT from plasma to
tissue during steady state, and b is a positive constant
equal to the equilibrium space of the exchangeable
compartments. Hence, if CPET(t)/Cp(t) is plotted against
u [5 0et Cp(u) du/Cp(t)], then during steady state (t . t*),
the curve should be a straight line with a positive
intercept and a slope equal to the rate constant K for
unidirectional uptake of [C-11]AMT from plasma to
tissue. The units of the rate constant K are ml/g/min.
Finally, the standardized uptake value (SUV) method
for semiquantitative analysis of tracer accumulation
(Kenney et al., 1941; Woodard et al., 1975) can be
applied to the data. The SUV is a method widely used to
assess metabolic activity in tumors using [F-18]fluoro-
deoxyglucose (Gupta et al., 1992; Strauss and Conti,
1991), because absolute values of the metabolic rate are
difficult to obtain due to several unknown variables in
tumors, including the lumped constant (LC), a factor
accounting for the differences between the kinetics of
the tracer and the natural substrate. Likewise, the LC
for [C-11]AMT in humans is unknown, and there are
differences in LC between the species for which it is
known. The LC was measured as 0.43 in rats (Vanier et
al., 1995) and 0.18 in rhesus monkeys (Shoaf and
Schmall, 1996). In addition, there is considerable contro-
versy in the literature regarding the fraction of trypto-
phan in blood available for transport into the brain,
which is the other factor necessary for calculation of the
absolute serotonin synthesis rate. The two main factors
that affect the availability of tryptophan to the brain
are the free plasma tryptophan concentration and the
plasma concentration of other large neutral amino
acids that compete with tryptophan for transport across
the blood-brain barrier (Bloxam et al., 1980; Fernstrom
and Wurtman, 1972; Fernstrom et al., 1973). The free
tryptophan concentration is determined by the degree
of binding to plasma albumin (Bloxam and Curzon,
1978; Gessa and Tagliamonte, 1974; Knott and Curzon,
1972). However, there is also evidence that tryptophan
bound to albumin is ‘‘stripped’’ from albumin as the
blood circulates through the brain (Pardridge, 1979;
Pardridge and Fierer, 1990; Yuwiler et al., 1977).
Furthermore, there is historical evidence to indicate
that serum total tryptophan is a better indicator of the
amount available for brain entry rather than free
tryptophan (Madras et al., 1973, 1974).
The SUV in different regions of the brain is equal to
the sum of the precusor [C-11]AMT and the metabolic
product [C-11]AM-5HT synthesized in these regions,
independent of the various physiologic processes affect-
ing the serotonin synthesis rate described above. The
SUV calculation relates tracer concentration in tissue
to the dose injected and the subject’s mass (Kenney et
al., 1941; Woodard et al., 1975) (SUV 5 tissue concen-
tration in regions of interest (ROI) (µCi/ml)/injected
dose per weight (mCi/kg).
Radiation dosimetry
The organ distribution (µCi/g) of [C-11]AMT, normal-
ized to injected activity and body weight, was deter-
mined in four rats (180–240 g) at 1 h after intravenous
injection of approximately 2 mCi of the tracer. Human
organ activity and residence times were estimated from
the rat data by using organ weights from IRCP Publica-
tion 53 (1988) and by assuming a total human body
weight of 70 kg. Final values of radiation dose were
calculated by using the residence time estimates and
the MIRDOSE program (Oak Ridge Institute for Sci-
ence and Education, Oak Ridge, TN, IBM PC Version
3.0, November 1994) (Table I). For [C-11]AMT, the
critical organs are the kidneys. The maximum allow-
able dose under Code of Federal Regulation guidelines
(resulting in a radiation exposure of 5 rem in one
session to the kidneys) is 55 mCi.
Subjects
Human subjects (n 5 10, five males, five females; age
range, 18–38 years; mean age, 28.3 years) were re-
cruited by advertisement and underwent a screening
interview to ensure the absence of mental or neurologic
disorders, and the use of centrally active pharmacologic
agents. Studies were performed in compliance with the
regulations of the Wayne State University Human
Investigation and Radioactive Drug Research Commit-
tees, and informed consent was obtained before all
studies.
PET protocol
PET studies with the tracer [C-11]AMT were per-
formed by using the CTI/Siemens EXACT/HR whole-
TABLE I. Radiation dose calculation (based on the MIRDOSE
program (IBM PC version 3.0—November ’94) provided by ORISE)
Organ mrem/mCi Organ mrem/mCi
Adrenals 13.0 Ovaries 17.6
Brain 8.8 Pancreas 13.0
Breasts 8.5 Red marrow 14.5








































Administered dose to human subjects: 0.4 mCi/kg
Total dose to 70-kg human: 28-mCi injection
Dose to critical organ (kidney): 2.56 rem
Effective dose equivalent: 0.56 rem
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body positron tomograph (Knoxville, TN). This scanner
has a 15-cm field of view and generates 47 image planes
with a slice thickness of 3.125 mm. The reconstructed
image in-plane resolution obtained is 5.5 6 0.35 mm at
full-width-at-half-maximum (FWHM) and 6.0 6 0.49
mm in the axial direction (reconstruction parameters:
Hanning filter with 0.20 cycles/pixel cutoff frequency).
Calculated attenuation correction was performed on all
images by using the technique described by Bergström
et al. (1982). [C-11]AMT was produced in 50–65%
radiochemical yield (decay corrected from [C-11]MeI) as
described by Chakraborty et al. (1996). Radiochemical
purity, determined by radio-HPLC, was greater than
98%. Specific activity of [C-11]AMT at time of injection
ranged from 500 to 1,000 Ci/mmol. The average injected
dose to the subjects was 30 mCi (23–38 mCi) and
contained 9 µg (3–16 µg) of AMT and 330 µg (100–535
µg) of L-tryptophan.
Subjects were fasted for 12 h before the PET proce-
dure to obtain stable plasma tryptophan levels during
the course of the study, as well as to minimize the
effects of insulin status, free fatty acid levels, and diet
on plasma protein binding of tryptophan and AMT. A
commercial SIEMENS/CTI head holder was used in
combination with Velcro strips to immobilize the pa-
tient’s head during the scan. A venous catheter was
established for tracer injection, and an arterial catheter
was placed in a percutaneous radial artery for collec-
tion of 28 timed arterial blood samples (0.5 ml/sample,
sequence: 18 3 10 sec, 2 3 1 min, 2 3 2.5 min, 2 3 5
min, 4 3 10 min). Radioactivity in plasma was mea-
sured by using a Cobra II gamma counter (Hewlett
Packard, Downers Grove, IL) which was calibrated
with the PET scanner. Metabolite-correction of the
plasma is unnecessary because metabolites [AM-5HT
(Minderaa et al., 1987), incorporation in plasma protein
(Diksic et al., 1991), and metabolites of the kynurenine
pathway (Madras and Sourkes, 1965; Sourkes, 1971)]
constitute less than 2% of the activity in plasma.
Plasma tryptophan concentrations (at zero, 10, 30, and
60 min) were measured by HPLC as described by
Krstulovic et al. (1979). Repeated measurements of
plasma tryptophan for each subject demonstrated a
constant value for plasma tryptophan for the duration
of the study and showed little variability among pa-
tients (range, 28–38 µM; mean, 32.4 µM 6 4.2 SD;
n 5 10) and no statistically significant difference be-
tween men (range, 26–37 µM; mean, 31.6 µM 1 4.0 SD;
n 5 5) and women (range, 28–38; mean, 33.6 µM 1 4.1
SD; n 5 5). The tracer [C-11]AMT (0.4 mCi/kg, 38 mCi
maximum) was injected intravenously as a slow bolus
over 2 min by using a Harvard pump. Beginning at the
time of injection, a 60-min dynamic PET scan of the
brain was performed (sequence: 4 3 30 sec, 3 3 1 min,
2 3 2.5 min, 10 3 5 min). Due to limited experience
with [C-11]AMT in humans, physiologic parameters
(heart rate, blood pressure, pulse oximetry, blood gases)
were measured periodically during the study. No ad-
verse reaction to infusion of [C-11]AMT was observed in
any of the subjects.
Data processing and analysis
To allow for efficient analysis of PET data, a software
package written in IDL v.4.0.1 (Research Systems Inc.,
Boulder, CO) and running under SunOS 4.1.3/Openwin-
dows 3.0 using a network of SUN Sparc IPX/Sparc 5
workstations (SUN Microsystems Inc., Mountain View,
CA) was developed. The software environment includes
motion correction of the dynamic frame sequence, non-
linear estimation of rate constants, and the estimation
of the unidirectional rate constant K according to
Equation 1 on a pixel-by-pixel basis.
Regions of interest
Brain ROIs were drawn on PET images calibrated to
µCi/ml, representing the retention of [C-11]AMT from
30 to 55 min, by an expert observer who defined ROIs
based on comparison of image activity distribution with
a Tallairach brain atlas. The time 30–55 min for
activity summation was chosen because it represents
the best contrast between activity in tissue and blood
pool. Because all subjects received a standardized dose
based on their weight (0.4 mCi/kg), calibrated images
directly depict the SUV value. ROIs were drawn in all
planes, showing a particular structure, and the average
concentration for individual structures was determined
by weighting the appropriate region concentration de-
termined in each plane by the size of the region in the
plane. These ROIs were also subsequently copied to
parametric images representing the unidirectional up-
take rate constant K as described below.
Nonlinear estimation procedure
Individual rate constants were estimated by using a
standard Marquardt-Levenberg least-squares algo-
rithm written in FORTRAN and invoked by the IDL
software package. For analysis of parameter identifiabil-
ity, the structure of the linearized model in the neighbor-
hood of the computed solution was used, thus yielding
the variance-covariance matrix.
Parametric images
To obtain a parametric image of the unidirectional
rate constant K, the Patlak graphic analysis was used
on a pixel-by-pixel basis. All frames starting from 20
min until the end of the study were used for a total of
eight frames. An average constant time-shift of 12 sec
was applied to the arterial blood input function to
account for the time-difference between the time-point
when activity reaches the brain and the time-point
when activity reaches the sampling site. The approach
produced a parametric image (47 planes) of the unidirec-
tional rate constant K. Subsequently, all previously
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defined ROIs were copied to these images, and the
weighted average over all planes in which the structure
appeared was obtained.
Statistical analyses
Multivariate analysis of variance (MANOVA) was
performed to test for gender and left/right differences of
regional values of the unidirectional uptake rate con-
stant K. The Friedman test (Siegel and Castellan, 1988)
was carried out to determine whether there were
significant differences among the regions in average
rank of K. The same analysis was used to determine
Kendall’s coefficient of concordance, which indicates the
degree of agreement among the subjects on the rank
order of the K values. Further analyses were performed
to evaluate the extent to which the rankings of K values
across regions were in agreement with the rank order of
regional serotonin content in human brain from the
literature (Bucht et al., 1981; Cochran et al., 1976;
Costa and Aprison, 1958; Mackay et al., 1978). Because
the regions could only be partially ordered based on the
literature, an adaptation of the Jonckheere test (Jonck-
heere, 1954) using the Ager-Brent partial order statis-
tic (Ager and Brent, 1978) was used. The K value for the
brainstem was excluded from this analysis (see Discus-
sion). A linear regression analysis yielding the correla-
tion coefficient was performed to relate regional values
of K versus regional SUV values. The SD and the
coefficient of variation (COV; 100% · SD/mean) for indi-
vidual rate constants were determined directly from
the variance-covariance matrix.
RESULTS
[C-11]AMT accumulated in whole brain for the first
20 min after bolus infusion, after which a plateau was
reached and maintained for up to 60 min. Mean brain
accumulation for men and women is shown in Figure
2A. The whole brain uptake of [C-11]AMT was low, with
less than 2% of the injected dose present in the brain at
peak values. [C-11]AMT concentration in whole brain
approached the concentration in blood by 40 min after
injection (Fig. 2B). The average values for the three-
compartment model first-order rate constants for whole
brain regions (supratentorial) were determined as
0.0129/min for K1 (COV 5 13%), 0.0292/min for k2
(COV 5 22%), and 0.0140/min for k3 (COV 5 34%). In
general, all parameters were correlated. The correla-
tion coefficient between parameters k2 and k3 was the
highest (r . 0.9). Nevertheless, for the whole brain
region the fitted curve represented the data well (Fig.
3), and the analysis of residuals did not reveal any bias.
The mean value for the metabolic pool (Cm) 50 min after
tracer injection was determined as 40% of total activity
(COV 5 10%) for women and 43% of total activity
(COV 5 12%) for men (Fig. 3). Different attempts to
constrain the parameter values to test whether a
smaller contribution of the metabolic pool could be
consistent with the data were unsuccessful, as these
curves did not fit the data well and clearly showed a
bias in the residuals.
The Patlak graphic approach requires dynamic equi-
librium of the tracer between the plasma and tissue
pools. The computed partition coefficient Cf (t)/Cp(t)
approached a constant value for times greater than 20
min in all brain ROIs, with the exception of the
cerebellum (Fig. 4) and white matter (not shown).
Therefore, the Patlak analysis was performed by using
time frames between 20 and 60 min. A representative
Patlak plot for three brain regions (Fig. 5) demon-
strates straight lines (r . 0.99) with a positive inter-
cept. In those regions that could be fitted, the K value
calculated by using the individual rate constants K1, k2,
and k3 (K1k3/(k2 1 k3)) agreed well with values of the
unidirectional rate constant K determined by using the
Patlak graphic approach, with exception of the cerebel-
Fig. 2. [C-11]AMT kinetics in plasma and brain. A: [C-11]AMT
accumulated in whole brain for the first 20 min after bolus injection
after which a plateau was reached and maintained for up to 60 min.
Normalized to unit dose per weight, accumulation was higher in
women than in men. B: The whole brain uptake of [C-11]AMT was low,
with less than 2% of the injected dose present in the brain at peak
values. [C-11]AMT concentration in brain approached the concentra-
tion in blood by 40 min after injection.
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lum and white matter. The Patlak analysis resulted in
overestimation of the unidirectional rate constant in
cerebellum and white matter due to the lack of dynamic
equilibrium in these regions during the time of the
study.
SUV images were generated by summing data ob-
tained between 30 and 55 min after injection and
revealed widespread distribution of the tracer through-
out brain gray matter (Fig. 6A). ROIs drawn on summed
images were used for brain regional analysis of [C-
11]AMT metabolism. Parametric image analysis of the
unidirectional rate constant K (Fig. 6B) was used to
determine regional values for serotonin synthesis capac-
ity (Table II). Regional values for K, obtained by
applying ROIs to the parametric images, resulted in
stable measurements of K, even for small brain struc-
Fig. 3. Three-compartment fit of a time-activity curve representing
[C-11]AMT whole brain tissue. Full circles represent actual data
points, and the full line indicate the least-squares fit to the data.
Individual rate constants were used to compute contributions from the
metabolic pool (thick broken line), the precursor pool (thin broken
line), and the blood volume tissue signal (not shown).
Fig. 4. Relationship between [C-11]AMT partition coefficient and
time in a typical normal subject. The quotient between the computed
free precursor pool time-activity curve Cf (t) and the measured plasma
time-activity curve Cp(t) of [C-11]AMT (which represents the partition
coefficient of [C-11]AMT) is displayed as a function of time and
approaches equilibrium for times greater than 20 min in the caudate,
frontal cortex, and thalamus but not in the cerebellum.
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tures. Regional values for SUV and K were highly
correlated within subjects (Fig. 7).
The rank order of values for the unidirectional up-
take rate constant K corresponded well to the distribu-
tion of serotonin content in human brain, with highest
values being measured in putamen, caudate, and thala-
mus. By using Friedman’s test, the rank order of
regional K values proved to be highly significant
(chi2 5 127.4, dof 5 19, P , .0001) (Table III). Further-
more, by using Kendall’s coefficient of concordance, the
average rank order correlation between pairs of sub-
jects over the regions was 0.634 (P , .0001). In addi-
tion, by using the Ager-Brent statistic, there was highly
significant agreement (P , .0001) between the rank
order of K and the a priori partial ordering of regions
based on regional serotonin content in human brain
from the literature (see Methods for references). Fur-
thermore, regional data values of K revealed gender
differences in serotonin synthesis capacity. Values in
women were significantly higher than those measured
in men throughout the brain (P , .05, MANOVA) and
were particularly higher in the transverse temporal
gyrus, anterior cingulate cortex, and cerebellar vermis.
There were no statistically significant left/right asym-
metries for any of the brain structures measured.
DISCUSSION
These studies demonstrate the suitability of [C-
11]AMT as a tracer for PET scanning for determining
regional serotonin synthesis capacity in human brain
and provide normal adult values for future comparison
with patient groups. The calculation of the absolute
serotonin synthesis rate requires knowledge of the
concentration of tryptophan in blood available for trans-
port into the brain and the LC (the brain/plasma
partition coefficients for tryptophan and AMT, as well
as the Km and Vmax of these substrates for tryptophan
hydroxylase). Although the LC for [C-11]AMT has been
measured in rats (Vanier et al., 1995) and in rhesus
monkeys (Shoaf and Schmall, 1996), it has not yet been
measured in humans. However, the LC is a constant for
the species and represents a mere scaling factor, which
does not affect differences among subjects. Further-
more, there is considerable controversy in the literature
regarding the fraction of tryptophan in blood available
for transport into the brain (see Theory). We have
attempted to minimize variability in plasma trypto-
phan by fasting all subjects for 12 h before the PET scan
and performing all studies at the same time of the day
(between 2 and 4 P.M.). Due to the standardized condi-
tions of our study protocol, there was little variability in
the plasma tryptophan concentration. Under these
conditions, the unidirectional uptake rate constant K is
the main predictor of serotonin synthesis rate, and it is
the only variable that reflects any dynamic information
obtained by the tracer kinetic model. In addition,
within a subject, differences in serotonin synthesis rate
between brain structures are directly related to K, as
the two other factors are common scaling factors for all
regions. Thus, any rank order obtained from measure-
ment of K is strictly valid for the serotonin synthesis
rate.
Furthermore, we obtained an excellent correlation
between regional values of K and regional SUVs. This
indicates that differences in tracer uptake in different
brain structures are mainly due to the unidirectional
uptake and metabolism of [C-11]AMT to [C-11]AM5-
HT. It also suggests that the free precursor pool is
homogeneous over brain structures and further sup-
ports our findings that the metabolic pool is of the same
order as the free precursor pool and thus can be
distinctly measured against the background of the free
precursor pool.
Although there is low uptake of the tracer in the
brain relative to other compounds commonly used for
PET imaging, variability of regional values among
normal subjects (Table II) is similar to those reported
for other tracers (e.g., COV reported by Holthoff et al.
[1991] ranged between 5 and 21% for [C-11]flumazenil).
Importantly, rank order of regional brain values for K is
consistent with the rank order for serotonin content in
human brain. Although the highest concentrations of
serotonin and various measures of innervation density
measured in vitro are localized to serotonergic cell
bodies in the brainstem nuclei, the brainstem was not
among the regions with high K values in the present
study. This finding is not unexpected, however, due to
the limits of the spatial resolution of PET technology
(reconstructed image in-plane resolution obtained is
5.5 6 0.35 mm at FWHM and 6.0 6 0.49 mm in the
Fig. 5. Patlak graphic analysis of three representative brain
regions in one subject. The slope of the regression line equals the rate
constant for unidirectional uptake of [C-11]AMT into tissue. CPET
represents total tissue [C-11] concentration (µCi/ml), CP denotes
[C-11]AMT concentration in plasma (µCi/ml), and u stands for the
expression (0etCP(u)du/CP(t)) in units of minutes. The regression
coefficient was higher than 0.99 for all curves.
39HUMAN BRAIN SEROTONIN SYNTHESIS CAPACITY
axial direction) compared with the small size of the
nuclei containing the several thousand serotonergic cell
bodies located near the midline of the brainstem (Tork,
1990; Tork and Hornung, 1990), as well as the problem
of partial volume in very small structures (Hoffman et
al., 1979). The rank order of K values for the remaining
brain regions in the present study shows a statistically
significant correlation with the rank order of serotonin
content in human brain. The highest values for seroto-
nin synthesis capacity were found in putamen, caudate,
thalamus, and hippocampus. Among cortical regions,
limbic areas such as rectal gyrus, anterior cingulate
Fig. 6. A: [C-11]AMT distribution in normal adult brain. Trans-
axial brain images at eight levels generated by summing data
obtained between 30 and 55 min after injection revealed widespread
distribution of the tracer throughout brain gray matter. B: Parametric
images of the unidirectional uptake rate constant K in normal adult
brain. Parametric images of the same brain levels shown in A.
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gyrus, and transverse temporal gyrus demonstrated
higher rates of serotonin synthesis than other regions
of the cortex. Serotonin content (Bucht et al., 1981;
Cochran et al., 1976; Costa and Aprison, 1958; Mackay
et al., 1978) and serotonin uptake carrier studies in
human brain (Cortes et al., 1988; Laruelle et al., 1988)
show that the values for cerebellum are very similar to
those measured in cerebral cortex. In the present study,
values of the unidirectional rate constant K for the
cerebellum were determined to be higher than those in
the cerebral cortex and hippocampus. However, be-
cause dynamic equilibrium is not approached in the
cerebellum during the study, the Patlak graphic analy-
sis is not valid in this brain region. The reason for the
apparently longer half-life of the free precursor pool in
the cerebellum as compared with other brain structures
is unclear and warrants further investigation.
In addition to metabolism by tryptophan hydroxy-
lase, tryptophan is metabolized by tryptophan 2,3-
dioxygenase (Haber et al., 1993) and indoleamine 2,3-
TABLE II. Brain regional values of serotonin synthesis capacity

















(R) 5.02 10 4.73 11 5.32 6
(L) 5.02 10 4.73 11 5.32 5
Frontal lobe
Frontal cortex
(R) 4.89 12 4.57 14 5.20 5
(L) 4.93 11 4.68 13 5.17 5
Rectal gyrus
(R) 5.94 13 6.29 15 5.51 5
(L) 5.78 17 5.99 22 5.52 7
Temporal lobe
Transverse
(R) 5.66 14 5.21 12 6.11 11
(L) 5.76 12 5.42 15 6.10 6
Superior
(R) 4.97 8 4.73 9 5.22 5
(L) 5.03 10 4.82 12 5.23 7
Middle
(R) 5.12 9 4.89 9 5.41 7
(L) 5.17 12 5.01 13 5.36 10
Inferior
(R) 5.00 10 4.87 14 5.13 5
(L) 4.93 12 4.76 13 5.14 10
Hippocampus
(R) 5.15 13 4.88 10 5.50 14
(L) 5.31 21 4.77 14 6.04 21
Other cortical regions
Parietal cortex
(R) 4.80 9 4.60 9 5.00 7
(L) 4.77 9 4.61 10 4.93 8
Occip. cortex
(R) 4.83 9 4.71 11 4.95 8
(L) 4.83 9 4.73 12 5.97 7
Anterior cingulate
(R) 5.57 11 5.17 9 5.00 8
(L) 5.66 11 5.36 13 5.96 5
Posterior cingulate
(R) 5.32 9 5.18 11 5.46 7
(L) 5.48 8 5.42 9 5.54 6
Subcortical structures
Caudate nucleus
(R) 5.90 14 5.69 19 6.11 9
(L) 5.68 13 5.21 11 6.16 8
Putamen
(R) 6.37 8 6.10 8 6.64 6
(L) 6.18 9 5.86 10 6.50 5
Thalamus
(R) 5.70 13 5.41 15 5.98 9
(L) 5.66 14 5.27 16 6.06 9
Brainstem 4.94 13 4.84 17 5.06 9
Cerebellum
Hemispheres
(R) 5.53 8 5.32 7 5.79 5
(L) 5.45 10 5.28 12 5.67 6
Vermis 5.69 13 5.24 8 6.26 11
White matter
Centrum semiovale 2.54 9 2.32 4 2.83 3
1Mean and percentage coefficient of variation (COV 5 100% 3 SD/mean) of K
complex are reported. (R 5 right, L 5 left).
Fig. 7. Unidirectional uptake rate constant K of [C-11]AMT into
tissue as a function of the standardized uptake value (SUV). The SUV
represents total accumulation of tracer into tissue normalized to the
injected activity and patient weight. Each point represents a specific
brain region in one representative subject. The correlation coefficient
is 0.90 (P , .05).







Transverse temporal gyrus 15.7
Thalamus 15.25
Anterior cingulate gyrus 14.75
Cerebellar hemispheres 14.65
Cerebellar vermis 13.8
Posterior cingulate gyrus 12.9
Hippocampus 12.0
Rectal gyrus 11.15




Inferior temporal gyrus 7.15
Superior temporal gyrus 6.95
Frontal cortex 5.5
Primary occipital cortex 5.1
Parietal cortex 4.55
Lateral occipital cortex 1.6
1The highest rank represents the region with highest serotonin synthesis
capacity.
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dioxygenase (Yamazaki et al., 1985) via the kynurenine
pathway in the brain. Under normal circumstances,
however, the metabolites of these pathways are be-
tween 100- and 1,000-fold lower than the concentration
of tryptophan in the brain (Saito et al., 1993). By
comparison, the sum of the concentrations of serotonin
and its metabolite 5-hydroxyindole acetic acid is approxi-
mately one-fifth the concentration of tryptophan in
brain (Hery et al., 1977). Therefore, the kynurenine
pathways are not expected to confound the interpreta-
tion of data in the present study. However, after isch-
emic brain injury or immune activation, induction of
indoleamine 2,3-dioxygenase can result in a 10-fold
increase in quinolinic acid in brain (Saito et al., 1993),
and therefore, under these circumstances this pathway
should be considered.
The gender differences in brain serotonin synthesis
observed in the present study are consistent with
reports in the literature of small but significantly
higher serotonin content (Carlsson et al., 1985; Kato,
1960; Rosencrans, 1970), higher 5-hydroxytryptophan
accumulation after inhibition of aromatic amino acid
decarboxylase (Carlsson et al., 1985; Watts and Stanley,
1984), and higher serotonin accumulation after mono-
amine oxidase inhibition (Carlsson et al., 1985; Rose-
crans, 1970) in female rats than in male rats. Further,
the differences between male and female rats persisted
after treatment with tryptophan, which produced brain
concentrations of tryptophan that saturated trypto-
phan hydroxylase, demonstrating that the gender differ-
ences in serotonin synthesis capacity were independent
of plasma tryptophan concentration (Carlsson and
Carlsson, 1988). Young et al. (1980) reported signifi-
cantly higher 5-HIAA in cerebrospinal fluid in women
than in men, suggesting a higher rate of serotonin
metabolism for women. Differences in the serotonin
synthesis between men and women may reflect gender
differences of importance to both normal and pathologic
behavior.
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